Related Topics
 

Gaston K. Rivera, MD


Gaston Rivera, MD

Medical Director, Chile Program

Research Interests

Selected Publications

Howard SC, Gajjar A, Ribeiro RC, Rivera GK, Rubnitz JE, Sandlund JT, Harrison PL, deArmendi A, Dahl GV, Pui C-H. Safety of lumbar puncture in children with acute lymphoblastic leukemia and thrombocytopenia. JAMA 284:2222-2224, 2000.

Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC, Sandlund JT, Rivera GK, Rubnitz JE, Ribeiro RC, Pui C-H, Campana D. Sequential monitoring of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 96:2691-2696, 2000.

Gajjar A, Harrison PL, Sandlund JT, Rivera GK, Ribeiro RC, Rubnitz JE, Relling MV, Evans WE, Boyett JM, Pui C-H. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood 96:3381-3384, 2000.

Relling MV, Pui C-H, Sandlund JT, Rivera GK, Hancock ML, Boyett JB, Schuetz EG, Evans WE. Adverse effect of anticonvulsants on the efficacy of chemotherapy for acute lymphoblastic leukemia. Lancet 356:285-290, 2000.

Pui C-H, Boyett JM, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC, Rubnitz JE, Behm FG, Raimondi SC, Gajjar A, Razzouk B, Campana D, Kun LE, Relling MV, Evans WE. Long-term results of total therapy studies 11, 12, and 13A for childhood acute lymphoblastic leukemia at St. Jude Children’s Research Hospital. Leukemia 14:2286-2294, 2000.

Leung W,  Hudson M, Harrison P, Boyett J, Zhu Y, Rivera GK, Ribeiro RC, Sandlund JT, Evans WE, Kun K, Pui C-H. Late effects in survivors of infant leukemias. Leukemia 14:1185-1190, 2000.

Woo MH, Hak LJ, Storm MC, Sandlund JT, Ribeiro RC, Rivera GK, Rubnitz JE, Harrison PL, Wang B, Evans WE, Pui C-H, Relling MV.  Hypersensitivity or development of antibodies to asparaginase do not impact treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 18:1525-1532, 2000.

Buchanan GR, Rivera GK, Pollock BH, Boyett JM, Chauvenet AR, Wagner H, Maybee DA, Crist WM, Pinkel D. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second marrow remission: A Pediatric Oncology Group Study. Cancer 88:1166-74, 2000.

Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, Pui C-H, Evans WE. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. JNCI 91(23):2001-2008, 1999.

Arnaout MK, Tamburro RF, Bodner SM, Sandlund JT, Rivera GK, Pui C-H, Ribeiro RC. Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemia. J Clin Oncol 21(5):431-435, 1999.

Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA, Kun LE, Walter AW, Evans WE, Pui C-H. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 354:34-39, 1999.

Woo MH, Relling MV, Sonnichsen DS, Rivera GK, Pratt CB, Pui C-H, Evans WE, Pappo AS. Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias. Clin Cancer Res 5(3):543-549, 1999.

Pui C-H, Boyett JM, Relling MV, Harrison PL, Rivera GK, Behm FG, Sandlund JT, Ribeiro RC, Rubnitz JE, Gajjar A, Evans WE. Sex differences in prognosis for children with acute lymphoblastic leukemia. J Clin Oncol 17(3):818-824, 1999.

Rubnitz JE, Behm FG, Wichlan D, Ryan C, Sandlund JT, Ribeiro RC, Rivera GK, Relling MV, Evans WE, Pui C-H, Downing JR. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup. Leukemia 13:19-21, 1999.

Rivera GK. Recent advances in the therapy of childhood acute lymphoblastic leukemia. Intl J Ped Hematol Oncol 5 (2-4): 71-73, 1998.

Walter AW, Hancock ML, Pui C-H, Hudson MM, Ochs J, Rivera GK, Pratt C, Boyett J, Kun LE. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St. Jude Children’s Research Hospital. J Clin Oncol 16:3761-3767, 1998.

Pui C-H, Rubnitz JE, Hancock ML, Downing JR, Raimondi SC, Rivera GK, Sandlund JT, Ribeiro RC, Head DR, Relling MV, Evans WE, Behm FG. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol 16(12):3768-3773, 1998.

Woo MH, Hak LJ, Storm MC, Evans WE, Sandlund JT, Rivera GK, Wang Bo, Pui C-H, Relling MV. Anti-asparaginase antibodies following E.coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia 12:1527-1533, 1998.

 

Last update: August 2003